| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.07B | 41.82B | 21.04B | 16.44B | 10.58B | 7.14B |
| Gross Profit | 5.41B | 5.65B | 3.56B | 2.21B | 1.55B | 1.17B |
| EBITDA | 2.69B | 2.01B | 1.04B | 609.73M | 372.49M | 245.05M |
| Net Income | 938.46M | 1.35B | 647.57M | 336.17M | 172.42M | 50.23M |
Balance Sheet | ||||||
| Total Assets | 51.11B | 52.94B | 35.75B | 21.49B | 10.93B | 9.05B |
| Cash, Cash Equivalents and Short-Term Investments | 17.95B | 19.21B | 9.54B | 7.55B | 1.99B | 2.04B |
| Total Debt | 5.35B | 4.76B | 5.94B | 3.03B | 1.18B | 2.27B |
| Total Liabilities | 45.80B | 47.66B | 31.94B | 18.38B | 9.88B | 8.17B |
| Stockholders Equity | 5.32B | 5.27B | 3.81B | 3.11B | 1.04B | 871.30M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.96B | -1.26B | 1.27B | 196.17M | 0.00 |
| Operating Cash Flow | 0.00 | 10.02B | -1.21B | 1.29B | 274.83M | 0.00 |
| Investing Cash Flow | 0.00 | -1.17B | -134.78M | -122.80M | 237.44M | -239.15M |
| Financing Cash Flow | 0.00 | -1.11B | 2.91B | 3.57B | -1.09B | 1.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥62.50B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ¥17.33B | 9.36 | ― | 2.86% | 36.31% | 52.62% | |
62 Neutral | ¥27.19B | 9.14 | ― | 0.66% | 10.67% | 6.94% | |
50 Neutral | ¥7.29B | 59.14 | ― | 0.96% | -23.90% | -146.54% | |
44 Neutral | ¥17.53B | -12.65 | ― | ― | -21.88% | 17.12% |